Autoimmune & Arthritis
Early Rheumatoid Arthritis Treatment Shows Promise for Rapid Remission
Small study tests whether tocilizumab can achieve faster, deeper remission in newly diagnosed rheumatoid arthritis patients.
Clinical Trial
Mar 28, 2026 3
All Articles
609 articles
Autoimmune & Arthritis
New Drug KPL-404 Shows Promise for Treatment-Resistant Rheumatoid Arthritis
Phase 2 trial tests novel therapy for patients who failed standard biologics and JAK inhibitors in 145-person study.
Clinical Trial
Mar 28, 2026 3
Autoimmune & Arthritis
New Rheumatoid Arthritis Drug Shows Promise for Treatment-Resistant Patients
Phase 3 trial tests otilimab against standard care in 550 patients who failed previous biologics and JAK inhibitors.
Clinical Trial
Mar 28, 2026 3
Autoimmune & Arthritis
JAK Inhibitor Shows Promise for Persistent Pain in Rheumatoid Arthritis Patients
Small study explores how tofacitinib may address chronic pain that persists even when inflammation is controlled in RA patients.
Clinical Trial
Mar 28, 2026 3
Autoimmune & Arthritis
Russian Study Develops AI Model to Predict Rheumatoid Arthritis Drug Response
Researchers used blood biomarkers and machine learning to predict which expensive RA treatments work best for individual patients.
Clinical Trial
Mar 28, 2026 3
Autoimmune & Arthritis
Abatacept Shows Promise for Immune System Reset in Rheumatoid Arthritis Patients
NYU study reveals how targeted immune therapy transforms inflammatory responses in rheumatoid arthritis treatment.
Clinical Trial
Mar 28, 2026 3
Cancer Research
Engineered T Cells Show Promise Against Deadly Mesothelioma Cancer
Small trial tests modified immune cells injected directly into chest cavity to fight aggressive cancer with 12-month survival rate.
Clinical Trial
Mar 28, 2026 1
Cancer Research
New Cancer Immunotherapy IBI346 Shows Promise in Multiple Myeloma Trial
Small trial tests innovative treatment IBI346 for blood cancer patients who didn't respond to standard therapies.
Clinical Trial
Mar 28, 2026 1
Cancer Research
CAR T-Cell Therapy Shows Promise Against Relapsed Blood Cancers in Small Trial
Engineered immune cells target CD19+ cancer cells in patients with treatment-resistant lymphoma and leukemia.
Clinical Trial
Mar 28, 2026 1
Cancer Research
Engineered T Cells Show Promise Against Childhood Cancers in Phase I Trial
Modified immune cells targeting GD2 protein demonstrated safety in treating aggressive childhood cancers like neuroblastoma and osteosarcoma.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Cancer Trial Tests Novel Immune Booster BAY 2416964 With Pembrolizumab
Researchers tested a new drug combination targeting immune suppression in advanced solid tumors before early termination.
Clinical Trial
Mar 28, 2026 0
Cancer Research
Immunotherapy Combination Shows Promise Against Advanced Sarcoma in Major Trial
Phase II trial tested nivolumab with or without ipilimumab in 164 patients with metastatic sarcoma that couldn't be surgically removed.
Clinical Trial
Mar 28, 2026 0